Publications by authors named "Yihe G Daida"

Background: Electronic health record (EHR) data are an underused source for lactation-related research. The validity of ICD-10-CM-coded lactational mastitis is unknown.

Methods: We assessed lactational mastitis diagnosis code validity by medical record review.

View Article and Find Full Text PDF

Background: Cardiovascular disease (CVD) is the leading cause of death in the United States, and rates of CVD incidence vary widely by race and ethnicity. Cigarette smoking is associated with increased risk of CVD. The purpose of the study was: 1) to examine smoking prevalence over time across Asian and Pacific Islander (API) and multi-race API subgroups; 2) to determine whether the CVD risk associated with smoking differed among these subgroups.

View Article and Find Full Text PDF

Introduction: Information about causes of injury is key for injury prevention efforts. Historically, cause-of-injury coding in clinical practice has been incomplete due to the need for extra diagnosis codes in the International Classification of Diseases-Ninth Revision-Clinical Modification (ICD-9-CM) coding. The transition to ICD-10-CM and increased use of clinical support software for diagnosis coding is expected to improve completeness of cause-of-injury coding.

View Article and Find Full Text PDF

Importance: Despite increasing numbers of multiracial individuals, they are often excluded in studies or aggregated within larger race and ethnicity groups due to small sample sizes.

Objective: To examine disparities in the prevalence of obesity among single-race and multiracial Asian and Pacific Islander individuals compared with non-Hispanic White (hereafter, White) individuals.

Design, Setting, And Participants: This cross-sectional study used electronic health record (EHR) data linked to social determinants of health and health behavior data for adult (age ≥18 years) members of 2 large health care systems in California and Hawai'i who had at least 1 ambulatory visit to a primary care practitioner between January 1, 2006, and December 31, 2018.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the age at lung cancer diagnosis and sex differences in individuals who never smoked, involving 33,793 participants from various regions including East Asia, the US, and the UK.
  • Results showed that in Chinese individuals, females were diagnosed at a younger age than males, with significant differences recorded in several locations, while patterns in other racial groups were inconsistent.
  • The findings suggest that there are notable sex differences in the age of diagnosis for lung cancer among non-smokers, highlighting the need for further research in this area.
View Article and Find Full Text PDF

Prescription opioid tapering has increased significantly over the last decade. Evidence suggests that tapering too quickly or without appropriate support may unintentionally harm patients. The aim of this analysis was to understand patients' experiences with opioid tapering, including support received or not received for pain control or mental health.

View Article and Find Full Text PDF

Objective: Eradication of hepatitis C virus (HCV) infection has been linked with improvement in neurocognitive function, but few studies have evaluated the effect of antiviral treatment/ response on risk of dementia. Using data from the Chronic Hepatitis Cohort Study (CHeCS), we investigated how antiviral therapy impacts the risk of developing dementia among patients with HCV.

Methods: A total of 17,485 HCV patients were followed until incidence of dementia, death, or last follow-up.

View Article and Find Full Text PDF
Article Synopsis
  • The FDA-approved 8-week treatment of glecaprevir/pibrentasvir (GLE/PIB) for chronic hepatitis C (HCV) in cirrhosis patients was evaluated using data from the Chronic Hepatitis Cohort Study (CHeCS).
  • 159 out of 166 patients achieved a sustained virological response (SVR), indicating a high effectiveness of the treatment.
  • Serious adverse events were generally low, with a small percentage of patients experiencing them, suggesting the regimen is well-tolerated in routine clinical care.
View Article and Find Full Text PDF

Introduction: Prevalence and severity of pruritus among US patients with chronic hepatitis B and C (HBV, HCV) are not well-documented. Chronic Hepatitis Cohort Study (CHeCS) patients were surveyed to examine pruritus prevalence and impact on quality of life (QoL).

Methods: Patients who reported experiencing pruritus ≥3 on a Numeric Rating Scale (NRS) within the past 30 days were invited to participate in a 6-month study using the SF-36 questionnaire.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic hepatitis C (HCV) significantly contributes to the development of hepatocellular carcinoma (HCC), and while antiviral treatments like direct-acting antivirals (DAA) lower the risk of HCC, the long-term effects of different treatment types were previously unclear.
  • A study using data from the Chronic Hepatitis Cohort evaluated the risk of HCC based on treatment type and whether the patient achieved sustained virological response (SVR) or treatment failure, ultimately identifying cirrhosis as the strongest risk factor and highlighting DAA SVR as more effective than interferon-based treatments in reducing HCC risk.
  • The researchers developed a six-variable predictive model that shows excellent accuracy for identifying HCC risk factors in
View Article and Find Full Text PDF
Article Synopsis
  • Cardiovascular disease (CVD) is the top cause of death in the US, with various demographic and cultural factors influencing its incidence, particularly among Asian and Pacific Islander (API) populations, but research on these groups is limited.
  • The study analyzed the health records of over 684,000 adult patients from two medical foundations to assess coronary heart disease (CHD), stroke, peripheral vascular disease (PVD), and overall CVD across different API subpopulations.
  • Findings revealed significant disparities in CVD prevalence, with Filipinos showing the highest rates and Chinese individuals the lowest; multi-racial groups generally had higher CVD prevalence compared to single-race groups, highlighting the complexity of health disparities within APIs.
View Article and Find Full Text PDF

Background: All families experience financial and time costs related to caring for their children's health. Understanding the economic burden faced by families of children with chronic health conditions (CHC) is crucial for designing effective policies to support families.

Methods: In this prospective study we used electronic health records to identify children between 3 and 17 years old with autism spectrum disorder (ASD), asthma, or neither (control) from three Kaiser Permanente regions and several community health centers in the OCHIN network.

View Article and Find Full Text PDF

Research suggests a possible link between chronic infection with hepatitis C virus (HCV) and the development of Parkinson's Disease (PD) and secondary Parkinsonism (PKM). We investigated the impact of antiviral treatment status (untreated, interferon [IFN] treated, direct-acting antiviral [DAA] treated) and outcome (treatment failure [TF] or sustained virological response [SVR]) on risk of PD/PKM among patients with HCV. Using data from the Chronic Hepatitis Cohort Study (CHeCS), we applied a discrete time-to-event approach with PD/PKM as the outcome.

View Article and Find Full Text PDF